ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Tango Therapeutics to go public with $353m merger deal pharmaceutical-technology
April 16, 2021Tango Therapeutics is set to go public with the signing of a definitive merger agreement with the Boxer Capital-sponsored special purpose acquisition company BCTG Acquisition worth up to a total of approximately $353m. -
ViiV posts positive long-term data for two-drug HIV regimen Dovato pharmatimes
October 14, 2020GlaxoSmithKline subsidiary ViiV Healthcare has reported new data for its two-drug HIV regimen Dovato, with hopes that the long-term data could encourage clinicians to switch from other triple regimen therapies.
Pharma Sources Insight January 2025
